Prospective, Randomised, Placebo Controlled, Double Blind Monocenter Trial for the Prophylactic Treatment of Diarrhoea With Rifaximin for Travellers to South- and Southeast-Asia.

Trial Profile

Prospective, Randomised, Placebo Controlled, Double Blind Monocenter Trial for the Prophylactic Treatment of Diarrhoea With Rifaximin for Travellers to South- and Southeast-Asia.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Nov 2013

At a glance

  • Drugs Rifaximin (Primary)
  • Indications Traveller's diarrhoea
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Jun 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2007-003986-42).
    • 19 Mar 2012 Planned end date changed from 1 Apr 2011 to 1 Oct 2012 as reported by ClinicalTrials.gov.
    • 19 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top